Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evan R Myers

Showing results (31-40 of 203) with videos related to

Pageof 21
Sort By:
American Journal of Obstetrics and Gynecology|April 27, 2010
Impact of a chemoresponse assay on treatment costs for recurrent ovarian cancerLaura J Havrilesky, Thomas C Krivak, John W Mucenski, et al.
Gynecologic Oncology|December 23, 2008
Cost effectiveness of a test to detect metastases for endometrial cancerLaura J Havrilesky, G Larry Maxwell, John K Chan, et al.
American Journal of Obstetrics and Gynecology|March 23, 2020
Addressing heterogenous outcomes in uterine fibroid research: a call to actionAnnie P Tran, Jennifer Al Naber, Ellen S Tambor, et al.
Gynecologic Oncology|March 26, 2005
FDG-PET for management of cervical and ovarian cancerLaura J Havrilesky, Shalini L Kulasingam, David B Matchar, et al.
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|January 27, 2022
Cost comparison of using reusable versus disposable equipment for retinopathy of prematurity screening roundsJennifer M Chang-Wolf, Evan R Myers, Sharon F Freedman, et al.
Cost Effectiveness and Resource Allocation : C/E|February 19, 2008
Adding a quadrivalent human papillomavirus vaccine to the UK cervical cancer screening programme: A cost-effectiveness analysisShalini L Kulasingam, Steve Benard, Ruanne V Barnabas, et al.
Seminars in Reproductive Medicine|April 24, 2013
How Obamacare will impact reproductive healthPaul R Brezina, Anish A Shah, Evan R Myers, et al.
Epidemics|May 17, 2015
Impact of coverage-dependent marginal costs on optimal HPV vaccination strategiesMarc D Ryser, Kevin McGoff, David P Herzog, et al.
Genetic Epidemiology|December 2, 2017
Estimating the number of potential family members eligible for BRCA1 and BRCA2 mutation testing in a "Traceback" approachHaley A Moss, Goli Samimi, Laura J Havrilesky, et al.
Gynecologic Oncology|September 29, 2007
Primary surgery versus chemoradiation in the treatment of IB2 cervical carcinoma: a cost effectiveness analysisElizabeth L Jewell, Shalini Kulasingam, Evan R Myers, et al.
Pageof 21

Showing results (31-40 of 203) with videos related to

Sort By:
Pageof 21
American Journal of Obstetrics and Gynecology|April 27, 2010
Impact of a chemoresponse assay on treatment costs for recurrent ovarian cancerLaura J Havrilesky, Thomas C Krivak, John W Mucenski, et al.
Gynecologic Oncology|December 23, 2008
Cost effectiveness of a test to detect metastases for endometrial cancerLaura J Havrilesky, G Larry Maxwell, John K Chan, et al.
American Journal of Obstetrics and Gynecology|March 23, 2020
Addressing heterogenous outcomes in uterine fibroid research: a call to actionAnnie P Tran, Jennifer Al Naber, Ellen S Tambor, et al.
Gynecologic Oncology|March 26, 2005
FDG-PET for management of cervical and ovarian cancerLaura J Havrilesky, Shalini L Kulasingam, David B Matchar, et al.
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|January 27, 2022
Cost comparison of using reusable versus disposable equipment for retinopathy of prematurity screening roundsJennifer M Chang-Wolf, Evan R Myers, Sharon F Freedman, et al.
Cost Effectiveness and Resource Allocation : C/E|February 19, 2008
Adding a quadrivalent human papillomavirus vaccine to the UK cervical cancer screening programme: A cost-effectiveness analysisShalini L Kulasingam, Steve Benard, Ruanne V Barnabas, et al.
Seminars in Reproductive Medicine|April 24, 2013
How Obamacare will impact reproductive healthPaul R Brezina, Anish A Shah, Evan R Myers, et al.
Epidemics|May 17, 2015
Impact of coverage-dependent marginal costs on optimal HPV vaccination strategiesMarc D Ryser, Kevin McGoff, David P Herzog, et al.
Genetic Epidemiology|December 2, 2017
Estimating the number of potential family members eligible for BRCA1 and BRCA2 mutation testing in a "Traceback" approachHaley A Moss, Goli Samimi, Laura J Havrilesky, et al.
Gynecologic Oncology|September 29, 2007
Primary surgery versus chemoradiation in the treatment of IB2 cervical carcinoma: a cost effectiveness analysisElizabeth L Jewell, Shalini Kulasingam, Evan R Myers, et al.
Pageof 21